Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer.
Jahid S, Ortega JA, Vuong LM, Acquistapace IM, Hachey SJ, Flesher JL, La Serra MA, Brindani N, La Sala G, Manigrasso J, Arencibia JM, Bertozzi SM, Summa M, Bertorelli R, Armirotti A, Jin R, Liu Z, Chen CF, Edwards R, Hughes CCW, De Vivo M, Ganesan AK.
Jahid S, et al. Among authors: bertorelli r.
Cell Rep. 2022 Apr 5;39(1):110641. doi: 10.1016/j.celrep.2022.110641.
Cell Rep. 2022.
PMID: 35385746
Free PMC article.